Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jun 2;9(6):e97501.
doi: 10.1371/journal.pone.0097501. eCollection 2014.

Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis

Sooah Kim  1 , Jiwon Hwang  2 , Jinhua Xuan  1 , Young Hoon Jung  1 , Hoon-Suk Cha  2 , Kyoung Heon Kim  1
Affiliations

Global metabolite profiling of synovial fluid for the specific diagnosis of rheumatoid arthritis from other inflammatory arthritis

Sooah Kim et al. PLoS One. .

Abstract

Currently, reliable biomarkers that can be used to distinguish rheumatoid arthritis (RA) from other inflammatory diseases are unavailable. To find possible distinctive metabolic patterns and biomarker candidates for RA, we performed global metabolite profiling of synovial fluid samples. Synovial fluid samples from 38 patients with RA, ankylosing spondylitis, Behçet's disease, and gout were analyzed by gas chromatography/time-of-flight mass spectrometry (GC/TOF MS). Orthogonal partial least-squares discriminant and hierarchical clustering analyses were performed for the discrimination of RA and non-RA groups. Variable importance for projection values were determined, and the Wilcoxon-Mann-Whitney test and the breakdown and one-way analysis of variance were conducted to identify potential biomarkers for RA. A total of 105 metabolites were identified from synovial fluid samples. The score plot of orthogonal partial least squares discriminant analysis showed significant discrimination between the RA and non-RA groups. The 20 metabolites, including citrulline, succinate, glutamine, octadecanol, isopalmitic acid, and glycerol, were identified as potential biomarkers for RA. These metabolites were found to be associated with the urea and TCA cycles as well as fatty acid and amino acid metabolism. The metabolomic analysis results demonstrated that global metabolite profiling by GC/TOF MS might be a useful tool for the effective diagnosis and further understanding of RA.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1
Figure 1. OPLS-DA of the metabolite profiles of RA and non-RA groups.
(a) Score plot of the OPLS-DA model for RA and non-RA groups (tP, score of the non-orthogonal component; tO, score of the orthogonal component). (b) V-plot with p(corr) and VIP values of 105 metabolites. The metabolites with p(corr) <0 were those decreased in RA groups while the metabolites with p(corr) >0 were those increased in RA groups.
Figure 2
Figure 2. HCA of 105 metabolites from synovial fluid samples of RA and non-RA patients.
Each column and row represents a disease and an individual metabolite, respectively.
Figure 3
Figure 3. ROC analysis of the predictive power of the 20 combined biomarkers for distinguishing RA and non-RA groups.
A sensitivity and specificity were 92.3% and 68.0%, respectively, and the value of AUC was 0.812.
Figure 4
Figure 4. Schematic comparison of the primary metabolisms of RA vs. non-RA groups (AS, BD, and GO).
The box and whisker plots indicate the intracellular metabolite levels for each disease group (red, increased in RA; green, increased in non-RA). AcCOA, acetyl-CoA; ALA, alanine; ARG, arginine; ARG-SUC, arginine-succinate; ASN, asparagine; ASP, aspartate; CIT, citrate; CITR, citrulline; CMP, carbamoyl phosphate; FAs, fatty acids; FUM, fumarate; GLC, glucose; GLN, glutamine; GLU, glutamate; αKG, α-ketoglutarate; LYS, lysine; MAL, malate; OA, oxalate; ORNT, ornithine; PEP, phosphoenolpyruvate; PHA, phenylalanine; PRO, proline; SER, serine; SUCC, succinate; TRP, tryptophan; TYR, tyrosine.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cammarata RJ, Rodnan GP, Fennell RH (1967) Serum anti-γ-globulin and antinuclear factors in the aged. JAMA-J Am Med Assoc 199: 455–458. - PubMed
    1. Litwin SD, Singer JM (1965) Studies of the incidence and significance of anti-gamma globulin factors in the aging. Arthritis Rheum 8: 538–550. - PubMed
    1. Rantapaa-Dahlqvist S, de Jong BAW, Berglin E, Hallmans G, Wadell G, et al. (2003) Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 48: 2741–2749. - PubMed
    1. Humphreys JH, Symmons DP (2012) Postpublication validation of the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: where do we stand? Curr Opin Rheumatol 25(2): 157–163. - PubMed
    1. Kallberg H, Padyukov L, Plenge RM, Ronnelid J, Gregersen PK, et al. (2007) Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis. Am J Hum Genet 80: 867–875. - PMC - PubMed

Publication types

Grants and funding

This work was supported by the Advanced Biomass R&D Center of Korea (2011-0031353) and the National Foundation of Research (2013059103), both funded by the Korean Government. Experiments were performed by using the facilities of the Institute of Biomedical Science and Food Safety at the Korea University Food Safety Hall. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.